‘Socialized Research’ and ‘Privatized Profits’: California's Gene Therapy Research and Million Dollar Plus Treatments
By David Jensen,
The California Stem Cell Report
| 08. 09. 2021
“One and Done” — If Companies Actually Go to Market
Only eight days after the California stem cell agency approved its most recent award for its $60 million battle against sickle cell disease came a cautionary note from 3,000 miles away.
The note sounded financial misgivings regarding the proposed, gene-editing treatments that have been highly touted as a possible cure for sickle cell disease, an affliction that occurs predominantly among African-Americans and other minorities.
The concerns came from the 60-member Congressional Black Caucus. Million-dollar plus price tags were the main matter for the federal lawmakers. “We are troubled that access to these medicines is anything but guaranteed for the patients who would benefit most from them,” the lawmakers said in a letter to the head of the mammoth U.S. Department of Health and Human Services.
The timing of the July 28 letter appears merely coincidental to the approval on July 20 of an $8.4 million gene-therapy grant by the California Institute for Regenerative Medicine (CIRM), as the stem cell agency is officially known.
The caucus letter was not directed at CIRM, which is likely not even on the lawmakers’...
Related Articles
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...
By Roxanne Khamsi, The Atlantic | 07.07.2026
When Ludivine Verboogen and Romain Alderweireldt’s third child was born in Belgium in late 2015, they marveled at his long fingers. Perhaps one day he will be a famous pianist, they thought. But soon Ludivine grew worried that her son...
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Michael Le Page , New Scientist | 06.25.2026
We now know the master gene that controls embryonic development in people. Called NANOG, its role has been identified by making precise changes to the DNA of fertilised eggs using a technique called CRISPR base editing.
The discovery might lead...
